Chief Financial Officer
Neulogy VenturesCheck size: €200K-€3M investments, as published by Neulogy Ventures.
Martin Smetana is listed in a Chief Financial Officer capacity at Neulogy Ventures. The firm does not publish a person-specific investment thesis for this role; firm strategy is included only as shared context.
Moonshot ideas that push technology, climate or health forward, led by humble and competent founders with audacious long-term ambition.
Companies without meaningful innovation, Slovak operating relevance or a fit with the firm's technology, climate and health mandate are less aligned.
Show the technical frontier, founder insight, evidence, Slovak or CEE connection, positive impact and milestones that €200K-€3M can unlock.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Martin Smetana is a current Chief Financial Officer at Neulogy Ventures, according to the firm's official roster. No education, prior employment or personal deal claims are inferred where the firm does not publish them.